# of Displayed Technologies: 3 / 3

Applied Category Filter (Click To Remove): Small Molecules


Treatment of Multiple Sclerosis with small molecule IL-6/STAT3 inhibitors
TS-038701 — Small-molecule prodrugs that target IL-6/STAT3 signaling pathway.
Multiple Sclerosis (MS), an unpredictable and disabling autoimmune disease affecting the central nervous system, is the leading cause of non-traumatic neurological disability in young adults. There have been important advances in MS therapy, such as drugs that slow the progression of the disease a…
  • College: College of Medicine (COM)
  • Inventors: Yang, Yuhong; Li, Chenglong; Racke, Michael
  • Licensing Officer: Flammang, Ann Marie

Novel bacterial Type II topoisomerase inhibitors for the treatment of bacterial infections
TS-037293 — Bacterial infections such as sexually transmitted diseases, meningitis, pneumonia, tuberculosis (TB), and tetanus are some of the most common infectious diseases. However, there are few drugs that can be used against all of these diseases, and several bacteria have developed resistance to many com…
  • College: College of Pharmacy
  • Inventors: Mitton-Fry, Mark
  • Licensing Officer: Flammang, Ann Marie

Small Molecule Modulators as a Means to Control Tomato Bacterial Canker
TS-014936 — Small molecule modulators of Clavibacter michiganensis subsp. michiganensis (Cmm) as a means to control tomatobacterial canker.
Current efforts to control tomato cankers rely heavily on copper bactericides and antibiotics. These methods have significant limitations in that they exhibit limited efficacy in treatment and may promote pathogen resistance. Common strategies for controlling tomato bacterial canker mainly rely on…
  • College: College of Food, Agricultural, and Environmental Sciences (CFAES)
  • Inventors: Rajashekara, Gireesh; Fuchs, James; Miller, Sally; Nislow, Corey; Xu, Xiulan
  • Licensing Officer: Dahlman, Jason "Jay"

Loading icon